论文信息 - A cis-eQTL in NSUN2 promotes esophageal squamous-cell carcinoma progression and radiochemotherapy resistance by mRNA-m5C methylation - 字舞流文

A cis-eQTL in NSUN2 promotes esophageal squamous-cell carcinoma progression and radiochemotherapy resistance by mRNA-m5C methylation

Linna Peng | Jiahui Chu | W. Tan | Chen Wu | D. Lin | Chuan-wang Miao | Xinyu Yang | Xia Niu | Weiling Liu | Xinjie Chen | W. Tan

[1] Sina A. Gharib,et al. Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression , 2021, Nature Genetics.

[2] Zhen Zhang,et al. Comparing Paclitaxel Plus Fluorouracil Versus Cisplatin Plus Fluorouracil in Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Cancer: A Randomized, Multicenter, Phase III Clinical Trial , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3] Lei Zhang,et al. CCGD-ESCC: A Comprehensive Database for Genetic Variants Associated with Esophageal Squamous Cell Carcinoma in Chinese Population , 2018, Genom. Proteom. Bioinform..

[4] C. Abnet,et al. Epidemiology of Esophageal Squamous Cell Carcinoma. , 2017, Gastroenterology.

[5] W. Liang,et al. A randomized, multicenter phase III clinical trial comparing gemcitabine and cisplatin with 5-fluorouracil and cisplatin in the treatment of recurrent or metastatic nasopharyngeal carcinoma. , 2014 .

[6] Eyal Gottlieb,et al. TIGAR, a p53-Inducible Regulator of Glycolysis and Apoptosis , 2006, Cell.